Child health at two years corrected age after antenatal exposure to dexamethasone or betamethasone; a randomised trial

产前接触地塞米松或倍他米松后两年校正年龄的儿童健康状况；

• 批准号: nhmrc : 565403
• 负责人: A/Pr Philippa Middleton
• 金额: $ 118.53万
• 依托单位: The University of Adelaide
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/child-health-years-randomised-trial/98769
• 关键词: Child; health; two; years; corrected

Both dexamethasone or betamethasone, given to women at risk of preterm birth substantially improve neonatal and child health. There are conflicting reports as to whether dexamethasone is better than betamethasone? This randomised trial will assess this. If dexamethasone is more beneficial, there will be fewer deaths and fewer disabled children. This will be of great importance for the care of women at risk of preterm birth, their children and health services in Australia and internationally.

对有早产风险的妇女给予地塞米松或倍他米松均可显著改善新生儿和儿童健康。关于地塞米松是否优于倍他米松，有相互矛盾的报道。这项随机试验将对此进行评估。如果地塞米松更有效，死亡人数和残疾儿童就会减少。这对澳大利亚和国际上有早产危险的妇女及其子女的护理和保健服务具有重要意义。